Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1996-3-12
|
pubmed:abstractText |
This study was designed to investigate the role of nitric oxide (NO) in the formation of pancreatic edema in caerulein-induced pancreatitis in rats. Pancreatitis was produced by two intraperitoneal injections of caerulein, and plasma amylase concentration, pancreatic edema index (pancreatic wet weight/body weight), and Evans blue extravasation (as a measure of vascular permeability) were evaluated 5 h after the first injection. Four doses (1, 2.5, 5, and 10 mg/kg) of NG-nitro-L-arginine (L-NNA), an NO synthase inhibitor, were subcutaneously administered at -0.5, 0.5, 1.5, 2.5, and 3.5 h after the first injection of caerulein. L-NNA significantly lowered the edema index, the wet/dry weight ratio of the pancreas, and Evans blue extravasation in the rats with pancreatitis. The maximal effect was obtained by L-NNA at a dose of 2.5 mg/kg; this inhibited the increase in pancreatic edema formation from the control value by 60%-70%. Intraperitoneal injections (20 mg/kg, five times) of L-arginine, a substrate for NO production, partly reversed the L-NNA-induced inhibition of pancreatic edema formation, but D-arginine, an enantiomer of L-arginine, did not show any effect. Plasma amylase concentrations were not significantly affected by any dose of L-NNA, nor were they affected by L- or D-arginine. These findings strongly suggest that endogenous NO plays an important role in the formation of pancreatic edema in caerulein-induced pancreatitis in rats, probably by increasing vascular permeability and protein extravasation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amylases,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Caerulein,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Evans Blue,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0944-1174
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
636-42
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8574337-Acute Disease,
pubmed-meshheading:8574337-Amylases,
pubmed-meshheading:8574337-Animals,
pubmed-meshheading:8574337-Arginine,
pubmed-meshheading:8574337-Caerulein,
pubmed-meshheading:8574337-Capillary Permeability,
pubmed-meshheading:8574337-Dose-Response Relationship, Drug,
pubmed-meshheading:8574337-Edema,
pubmed-meshheading:8574337-Enzyme Inhibitors,
pubmed-meshheading:8574337-Evans Blue,
pubmed-meshheading:8574337-Male,
pubmed-meshheading:8574337-Nitric Oxide,
pubmed-meshheading:8574337-Nitroarginine,
pubmed-meshheading:8574337-Pancreatitis,
pubmed-meshheading:8574337-Rats,
pubmed-meshheading:8574337-Rats, Wistar
|
pubmed:year |
1995
|
pubmed:articleTitle |
Nitric oxide modulates pancreatic edema formation in rat caerulein-induced pancreatitis.
|
pubmed:affiliation |
Third Department of Internal Medicine, Tohoku University School of Medicine, Miyagi, Japan.
|
pubmed:publicationType |
Journal Article
|